Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 13 results:
Author Title [ Type(Desc)] Year
Filters: Author is Hernan, M. A.  [Clear All Filters]
Journal Article
A. Alonso, Jick, S. S., and Hernan, M. A., “Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis”, Neurology, vol. 66, pp. 572-5, 2006.
A. Alonso, Jick, S. S., Jick, H., and Hernan, M. A., “Antibiotic use and risk of multiple sclerosis”, Am J Epidemiol, vol. 163, pp. 997-1002, 2006.
A. Alonso, Logroscino, G., Jick, S. S., and Hernan, M. A., “Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study”, BMC Neurol, vol. 10, p. 6, 2010.
B. A. Dickerman, Garcia-Albeniz, X., Logan, R. W., Denaxas, S., and Hernan, M. A., “Avoidable flaws in observational analyses: an application to statins and cancer”, Nat Med, 2019.
M. A. Hernan, Jick, S. S., Logroscino, G., Olek, M. J., Ascherio, A., and Jick, H., “Cigarette smoking and the progression of multiple sclerosis”, Brain, vol. 128, pp. 1461-5, 2005.
A. Alonso, Rodriguez, L. A., Logroscino, G., and Hernan, M. A., “Gout and risk of Parkinson disease: a prospective study”, Neurology, vol. 69, pp. 1696-700, 2007.
A. Alonso, Logroscino, G., Jick, S. S., and Hernan, M. A., “Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study”, Eur J Neurol, vol. 16, pp. 745-51, 2009.
A. Alonso, Jick, S. S., Olek, M. J., and Hernan, M. A., “Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort”, J Neurol, vol. 254, pp. 1736-41, 2007.
M. A. Hernan, Logroscino, G., and Rodriguez, L. A. Garcia, “Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease”, Neurology, vol. 66, pp. 1097-9, 2006.
M. A. Hernan, Logroscino, G., and Rodriguez, L. A., “A prospective study of alcoholism and the risk of Parkinson's disease”, J Neurol, vol. 251 Suppl 7, pp. vII14-7, 2004.
A. Alonso, Jick, S. S., Olek, M. J., Ascherio, A., Jick, H., and Hernan, M. A., “Recent use of oral contraceptives and the risk of multiple sclerosis”, Arch Neurol, vol. 62, pp. 1362-5, 2005.
M. A. Hernan, Jick, S. S., Olek, M. J., and Jick, H., “Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study”, Neurology, vol. 63, pp. 838-42, 2004.
A. Alonso, Rodriguez, L. A., Logroscino, G., and Hernan, M. A., “Use of antidepressants and the risk of Parkinson's disease: a prospective study”, J Neurol Neurosurg Psychiatry, vol. 80, pp. 671-4, 2009.
[Page last reviewed 6 April 2021]